Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo, Mounjaro does not have to be injected at precisely the same clock time every week. What matters is that you take it once every seven days, on the same calendar day if possible, but you have a window of around four days either side of your usual day if you genuinely miss one — always check the Patient Information Leaflet for the exact guidance. Mounjaro is a prescription-only medicine and a clinician will confirm the routine that works best for your schedule during assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is Monday evening and you realise the pen is still in the fridge. You meant to inject that morning, you forgot, and now it is two days late. If you have taken Mounjaro at any point, this situation will probably feel familiar. The good news is that a two-day gap past your usual day does not void the dose or the week. According to the Mounjaro Summary of Product Characteristics on the eMC, if fewer than five days have passed since your scheduled injection, you can take it as soon as you remember and then return to your usual weekly schedule. If more than five days have passed, skip that dose entirely and wait for your next scheduled day.
That five-day rule is worth keeping somewhere visible, on your phone, on the fridge door. What it tells you is that the medicine's weekly design is robust. Tirzepatide has a half-life of around five days, which is precisely why the window exists. Missing by a day or two is very different from accidentally doubling up, which is the scenario to avoid. Never take two doses in the same week to make up for a skipped one.
If you are still getting started with Mounjaro, a broader overview of how the Mounjaro injection works may be a useful starting point before drilling into timing specifics.
You can change your injection day, and most people do at some point, holidays, shift patterns and family routines all shift. The rule is straightforward: your new injection day must be at least four days after the last dose you took. So if you injected on a Thursday and want to move to Monday permanently, you cannot do that the following Monday (only three days later). You would need to wait until the Monday after, making it ten days rather than seven for that single transition week. After that, Monday every week is fine.
This is also relevant if you are ever asking whether Mounjaro is a daily injection, it is not. Once weekly is the design, and the clinical evidence underpinning NICE's appraisal of tirzepatide was built on that schedule. Changing days occasionally does not invalidate your treatment; doing it regularly in a way that shortens intervals would, because it risks stacking doses and amplifying side effects.
A practical habit many people settle into: pick a day connected to something fixed, a gym session, a regular meeting, the day a repeat prescription arrives. The pen itself arrives in plain, unbranded packaging via DPD, with tracking, so there is usually a delivery notification you could use as a reminder anchor too.
Unlike some medicines where the time of day genuinely changes absorption or effect, Mounjaro's subcutaneous injection route means the precise clock hour matters very little for effectiveness. The medicine is absorbed slowly through subcutaneous tissue and reaches peak concentration gradually, so if you are wondering whether you have to inject Mounjaro at the same time each week, the short answer is that strict clock-hour precision is not required, though keeping to the same day matters far more. What the clinical programme studied was weekly dosing, and that is the interval the licensing reflects.
Side effect timing is a slightly different consideration. Some people find injecting in the evening means any initial nausea peaks while they are asleep, reducing its day-to-day impact. Others prefer mornings so they are alert to any unusual symptoms. Neither is clinically superior, it comes down to personal tolerance and routine. The NHS tirzepatide patient information page is a good reference for side effect patterns and what is typically expected as your body adjusts.
If you are weighing up timing alongside cost and whether private treatment fits your situation, our Mounjaro pricing page sets out what to expect from the private route. And if you have broader questions about the injection technique itself (whether the pen needs priming, for example) those are addressed separately.
Consistency becomes especially important at two moments: when you first start, and when your prescriber moves you to a higher dose. The starter dose of 2.5mg exists to let your system settle gradually, nausea and digestive discomfort are most common in the early weeks, and irregular timing in that window can make it harder to distinguish normal adjustment from something worth flagging. Once you reach a maintenance dose, a reliable weekly rhythm tends to correlate with better overall tolerability simply because the body adapts more predictably.
A question our prescribers hear regularly is whether any of this changes if you are switching from another GLP-1 medicine. It does not change the timing rule, but it may affect which day you start and what to expect in the first few weeks, a detail worth raising during your clinical review. For context on the wider treatment, our Mounjaro overview covers how tirzepatide works as a dual GIP and GLP-1 receptor agonist, which helps explain why the weekly schedule is structured the way it is.
If you are thinking about whether this treatment might be suitable for you and want a clinician to review your situation properly, you can start a free consultation with our team. A named GPhC-registered prescriber reads every submission and responds the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.